Literature DB >> 17673521

c-Kit in early onset of diabetes: a morphological and functional analysis of pancreatic beta-cells in c-KitW-v mutant mice.

Mansa Krishnamurthy1, Farzam Ayazi, Jinming Li, Alexander W Lyttle, Michael Woods, Yuexiu Wu, Siu-Pok Yee, Rennian Wang.   

Abstract

c-Kit tyrosine receptor kinase, a well-established stem cell marker, is expressed in a variety of tissues including the pancreas. The involvement of c-Kit in fetal rat and human endocrine pancreatic development, survival, and function has been well characterized but primarily using in vitro experimental approaches. Therefore, the aim of the current study was to examine whether deficiency of a functional c-Kit receptor would have physiological and functional implications in vivo. We characterized the c-Kit mutant mouse, c-Kit(W-v/+), to evaluate the in vivo role of c-Kit in beta-cell growth and function. Here we report that male c-Kit(W-v/+) mice, at 8 wk of age, showed high fasting blood glucose levels and impaired glucose tolerance, which was associated with low levels of insulin secretion after glucose stimulation in vivo and in isolated islets. Morphometric analysis revealed that beta-cell mass was significantly reduced (50%) in male c-Kit(W-v/+) mice when compared with controls (c-Kit(+/+)) (P < 0.05). In parallel, a reduction in pancreatic duodenal homeobox-1 and insulin gene expression in whole pancreas as well as isolated islets of c-Kit(W-v/+) male mice was noted along with a decrease in pancreatic insulin content. Furthermore, the reduction in beta-cell mass in male c-Kit(W-v/+) mice was associated with a decrease in beta-cell proliferation. Interestingly, these changes were not observed in female c-Kit(W-v/+) mice until 40 wk of age. Our results clearly demonstrate that the c-Kit receptor is involved in the regulation of glucose metabolism, likely through an important role in beta-cell development and function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17673521     DOI: 10.1210/en.2007-0387

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

Review 1.  β-Cell Receptor Tyrosine Kinases in Controlling Insulin Secretion and Exocytotic Machinery: c-Kit and Insulin Receptor.

Authors:  Amanda Oakie; Rennian Wang
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

2.  Long-term c-Kit overexpression in beta cells compromises their function in ageing mice.

Authors:  Amanda Oakie; Zhi-Chao Feng; Jinming Li; Jenna Silverstein; Siu-Pok Yee; Rennian Wang
Journal:  Diabetologia       Date:  2019-06-01       Impact factor: 10.122

3.  The platelet-derived growth factor (PDGF) family of tyrosine kinase receptors: a Kit to fix the beta cell?

Authors:  M Welsh
Journal:  Diabetologia       Date:  2012-06-14       Impact factor: 10.122

4.  Impact of obesity on the molecular response to a single bout of exercise in a preliminary human cohort.

Authors:  Patrick Vanderboom; Xiaoyan Zhang; Corey R Hart; Hawley E Kunz; Kevin J Gries; Carrie J Heppelmann; Yuanhang Liu; Surendra Dasari; Ian R Lanza
Journal:  Obesity (Silver Spring)       Date:  2022-05       Impact factor: 9.298

Review 5.  A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase.

Authors:  Zhi-Chao Feng; Matthew Riopel; Alex Popell; Rennian Wang
Journal:  Diabetologia       Date:  2015-02-03       Impact factor: 10.122

6.  Critical role of c-Kit in beta cell function: increased insulin secretion and protection against diabetes in a mouse model.

Authors:  Z C Feng; J Li; B A Turco; M Riopel; S P Yee; R Wang
Journal:  Diabetologia       Date:  2012-05-14       Impact factor: 10.122

7.  miR-10b-5p Rescues Diabetes and Gastrointestinal Dysmotility.

Authors:  Rajan Singh; Se Eun Ha; Lai Wei; Byungchang Jin; Hannah Zogg; Sandra M Poudrier; Brian G Jorgensen; Chanjae Park; Charles F Ronkon; Allison Bartlett; Sung Cho; Addison Morales; Yu Heon Chung; Moon Young Lee; Jong Kun Park; Andrés Gottfried-Blackmore; Linda Nguyen; Kenton M Sanders; Seungil Ro
Journal:  Gastroenterology       Date:  2021-01-07       Impact factor: 22.682

8.  TAZ promotes PDX1-mediated insulinogenesis.

Authors:  Mi Gyeong Jeong; Hyo Kyeong Kim; Gibbeum Lee; Hee Yeon Won; Da Hye Yoon; Eun Sook Hwang
Journal:  Cell Mol Life Sci       Date:  2022-03-13       Impact factor: 9.261

9.  Erythropoietin protects against diabetes through direct effects on pancreatic beta cells.

Authors:  Diana Choi; Stephanie A Schroer; Shun Yan Lu; Linyuan Wang; Xiaohong Wu; Yunfeng Liu; Yi Zhang; Herbert Y Gaisano; Kay-Uwe Wagner; Hong Wu; Ravi Retnakaran; Minna Woo
Journal:  J Exp Med       Date:  2010-12-13       Impact factor: 14.307

10.  Inhibition of Gsk3β activity improves β-cell function in c-KitWv/+ male mice.

Authors:  Zhi-Chao Feng; Lisa Donnelly; Jinming Li; Mansa Krishnamurthy; Matthew Riopel; Rennian Wang
Journal:  Lab Invest       Date:  2012-01-16       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.